Keyphrases
Mitogen-activated Protein Kinase
100%
Cannabinoids
100%
Lysophosphatidylinositol
100%
GPR55
100%
CB1 Receptor Antagonist
25%
Cannabidivarin
25%
Cannabis Sativa
25%
Signaling Pathway
12%
Therapeutic Targeting
12%
Antagonism
12%
Potent Inhibitor
12%
Phosphorylation
12%
ERK2
12%
Downstream Signaling
12%
Pharmacology
12%
Induced Activation
12%
Novel Therapeutics
12%
SR141716A
12%
Rimonabant
12%
AlphaScreen
12%
Assay Conditions
12%
Antinociceptive
12%
Pain Transmission
12%
Phytocannabinoids
12%
High-throughput System
12%
Mediated Action
12%
CB2 Ligands
12%
CB2 Receptor Agonist
12%
CB2 Receptor
12%
GW405833
12%
Partial Agonist
12%
Pharmacology, Toxicology and Pharmaceutical Science
Mitogen Activated Protein Kinase
100%
Cannabinoid
100%
Rimonabant
66%
Cannabinoid 1 Receptor Antagonist
66%
Cannabis Sativa
66%
Receptor
33%
Mitogen Activated Protein Kinase 3
33%
Cannabinoid 2 Receptor
33%
Cannabidivarin
33%
Tetrahydrocannabivarin
33%
Partial Agonist
33%
1 (2,3 Dichlorobenzoyl) 5 Methoxy 2 Methyl 3 (2 Morpholinoethyl)indole
33%
Cannabinoid 2 Receptor Agonist
33%